In a 2001 study, at week 16, patients had an average of 1.4 mm growth in length (25 percent increase) and a 106 percent increase in fullness and thickness.The results of the study resulted in Latisse® becoming the first and only FDA-approved treatment to lengthen, darken, and thicken eyelashes for people with insufficient lashes.